LONG-TERM OUTCOMES OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - THE SWEDISH PROSPECTIVE MULTICENTRE SVEAH EXTENSION STUDY

Isabella Visuri  1     Carl Eriksson  1     Sara Karlqvist  1     VYRON LYKIARDOPOULOS  2     Per Karlén  3     Olof Grip  4     Charlotte Söderman  5     Sven Almer  6     Erik Hertervig  6     Jan Marsal  6     Carolina Malmgren  7     Jenny Delin  8     Hans Strid  9     Mats Sjöberg  10     Daniel Bergemalm  10     Henrik Hjortswang  10     Jonas Halfvarson  10    
1 Örebro University, Örebro, Sweden
2 Linköping University, Linköping, Sweden
3 Danderyd Hospital, Stockholm, Sweden
4 Skåne University Hospital, Malmö/Lund, Sweden
5 Capio St Göran Hospital, Stockholm, Sweden
6 Karolinska Institutet, Stockholm, Sweden
7 Takeda Pharma A/B, Solna, Sweden
8 Ersta Hospital, Stockholm, Sweden
9 Södra Älvsborgs Hospital, Borås, Sweden
10 Skaraborgs Hospital, Lidköping, Sweden

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing